Centre Léon Bérard
Lyon's cancer centre, a world reference for sarcoma and rare cancers, led by Jean-Yves Blay, who also presides over UNICANCER.
Founded in 1923, the Centre Léon Bérard is the UNICANCER centre for the Auvergne-Rhône-Alpes region and the clinical arm of the Cancer Research Center of Lyon (CRCL, with Inserm, CNRS and Lyon 1). Under Jean-Yves Blay it coordinates the French NetSarc sarcoma network and the European Reference Network for rare adult solid cancers (EURACAN). Programmes include the ProfiLER molecular profiling study, a large early-phase unit, breast oncology under Thomas Bachelot, paediatric oncology (IHOPe) and a Lyon Integrated Cancer Research Site (LYriCAN). The International Agency for Research on Cancer sits in the same city.
- Sarcoma and rare cancers (NetSarc, EURACAN)
- ProfiLER precision oncology
- Early-phase trials
- Breast oncology
- Paediatric oncology (IHOPe)
Sarcoma expert who leads Centre Léon Bérard and the French cancer centre network UNICANCER.
Breast oncologist who led UNICANCER trials on brain metastases and hormone therapy resistance.
Pages like this
not linked directly; found by shared links- InstitutionInstitut Bergonié
Shares UNICANCER, Rare and paediatric cancers without markets, Comprehensive genomic profiling, Sarcomas (soft tissue, bone, GIST).
- ProductLapatinib
Shares Thomas Bachelot, HER2-positive breast cancer, Small-molecule kinase inhibitors.
- IdeaGrow immune command posts inside tumours
Shares Jean-Yves Blay, Sarcomas (soft tissue, bone, GIST), Melanoma, Immune checkpoint inhibitors.
- InstitutionTel Aviv Sourasky Medical Center
Shares Comprehensive genomic profiling, Sarcomas (soft tissue, bone, GIST), Immune checkpoint inhibitors, HR-positive / HER2-negative breast cancer.
- InstitutionGeneva University Hospitals (HUG)
Shares International Agency for Research on Cancer (IARC / WHO), Melanoma, Immune checkpoint inhibitors, HR-positive / HER2-negative breast cancer.
- IdeaOne standing umbrella trial for all rare cancers in a country
Shares UNICANCER, Rare and paediatric cancers without markets, Comprehensive genomic profiling, Sarcomas (soft tissue, bone, GIST).
- IdeaLet adolescents from age 12 into adult trials when the cancer biology is the same
Shares Rare and paediatric cancers without markets, Sarcomas (soft tissue, bone, GIST), Melanoma.
- InstitutionGhent University Hospital / Cancer Research Institute Ghent
Shares Comprehensive genomic profiling, Small-molecule kinase inhibitors, Melanoma, Immune checkpoint inhibitors.